[an error occurred while processing this directive]
Skip to Main Content

Latest News

April 19, 2010
Volume 88, Number 16
p. 10
Article appeared online April 16, 2010

A Shield Against Ricin

Drug Development: Small molecule defeats potential bioterrorism agent

Sophie Rovner

  • Print this article
  • Email the editor

Latest News



October 28, 2011

Speedy Homemade-Explosive Detector

Forensic Chemistry: A new method could increase the number of explosives detected by airport screeners.

Solar Panel Makers Cry Foul

Trade: U.S. companies complain of market dumping by China.

Novartis To Cut 2,000 Jobs

Layoffs follow similar moves by Amgen, AstraZeneca.

Nations Break Impasse On Waste

Environment: Ban to halt export of hazardous waste to developing world.

New Leader For Lawrence Livermore

Penrose (Parney) Albright will direct DOE national lab.

Hair Reveals Source Of People's Exposure To Mercury

Toxic Exposure: Mercury isotopes in human hair illuminate dietary and industrial sources.

Why The Long Fat?

Cancer Biochemistry: Mass spectrometry follows the metabolism of very long fatty acids in cancer cells.

Text Size A A

title

A whole-cell, high-throughput screen of thousands of small molecules has turned up a compound that protects mice from what would normally be a lethal dose of inhaled ricin, according to molecular biologist Daniel Gillet of the Alternative Energies & Atomic Energy Commission, in Gif sur Yvette, France, and cell biologist Ludger Johannes of the Curie Institute, in Paris (Cell 2010, 141, 231).

A large amount of ricin—one of the most toxic chemicals around—is produced as waste during the extraction of oil from castor beans. Already notorious for its use in the assassination of a Bulgarian defector in London during the Cold War, ricin could be dispersed as an aerosol in a bioterrorist attack, notes Vern L. Schramm, a biochemist at Albert Einstein College of Medicine of Yeshiva University, in New York City. Schramm’s own ricin work includes the development of a rapid assay that detects the toxin (Anal. Chem. 2009, 81, 2847).

No proven antidote is available at present. But the compound identified by the French researchers, a tricyclic imine called Retro-2, could be a promising lead for an anti-ricin drug, Schramm says.

Retro-2 works only if injected prior to ricin exposure. Gillet and Johannes are now trying to adapt the compound so it can be administered after exposure to the toxin.

The researchers are also trying to identify Retro-2’s molecular target. They have already determined that the compound blocks transport of ricin within a cell into the cytosol, preventing ricin from disrupting ribosomes that produce proteins needed for the cell to function.

Retro-2 might also offer protection against other toxins that operate via this same route, including Shiga-like toxins produced during infections by enterohemorrhagic Escherichia coli strains, which can cause kidney dysfunction and death. However, testing this hypothesis in mice is proving difficult as a result of regulations on the distribution of toxins. “We have been trying to purchase Shiga toxin 2 to perform our studies for over six months,” Gillet and Johannes note in an e-mail. They hope to obtain the material this year.

Chemical & Engineering News
ISSN 0009-2347
Copyright © 2011 American Chemical Society
  • Print this article
  • Email the editor

Services & Tools

ACS Resources

ACS is the leading employment source for recruiting scientific professionals. ACS Careers and C&EN Classifieds provide employers direct access to scientific talent both in print and online. Jobseekers | Employers

» Join ACS

Join more than 161,000 professionals in the chemical sciences world-wide, as a member of the American Chemical Society.
» Join Now!